Search

everythinglearnresearchcommunity

for

Search:↓

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

Docetaxel treatment for breast cancer can cause permanent hair loss.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Bortezomib chemotherapy can cause temporary skin rashes.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Cyclosporine may cause hair loss, so patients need monitoring.

Sorafenib can cause a unique skin reaction.

Prednisone treatment helped a woman with Cronkhite-Canada syndrome recover from hair loss and digestive issues.